Your browser doesn't support javascript.
loading
AHNAK2 promotes the progression of differentiated thyroid cancer through PI3K/AKT signaling pathway.
Xu, Min; Wen, Jialiang; Xu, Qiding; Li, Huihui; Lin, Bangyi; Bhandari, Adheesh; Qu, Jinmiao.
Afiliação
  • Xu M; Department of Operating Theatre, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, PR China.
  • Wen J; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, PR China.
  • Xu Q; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, PR China.
  • Li H; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, PR China.
  • Lin B; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, PR China.
  • Bhandari A; Department of Thyroid Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325000, PR China.
  • Qu J; Department of General Surgery, Breast and Thyroid Unit, Primera Hospital, Kathmandu, Nepal.
Curr Cancer Drug Targets ; 2022 Sep 08.
Article em En | MEDLINE | ID: mdl-36089788
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article